More Coronavirus Vaccines and Treatments Move Toward Human Trials

Just three months after the start of the coronavirus pandemic, several biotech companies are beginning trials of promising vaccines and treatments.
Source: NYT Health - Category: Consumer Health News Authors: Tags: Vaccination and Immunization Coronavirus (2019-nCoV) Drugs (Pharmaceuticals) Clinical Trials Epidemics Immune System Research DNA (Deoxyribonucleic Acid) RNA (Ribonucleic Acid) Biotechnology and Bioengineering Food and Drug Administrat Source Type: news

Related Links:

Conclusion: Although there is mathematical rationality behind implementation of social distancing measures including lockdown, this study also emphasised the importance of other associated measures like increasing tests and increasing the number of hospital and ICU beds. The later components are particularly important during the social mixing period to be observed after lifting of lockdown.
Source: Indian Journal of Public Health - Category: International Medicine & Public Health Authors: Source Type: research
Discussions with the FDA are ongoing to define the required data set for filing Janssen’s Ebola vaccine regimen under the FDA’s Animal Rule licensure pathway. About Janssen’s Ebola Vaccine Regimen The Janssen investigational preventive Ebola vaccine regimen (Ad26.ZEBOV, MVA-BN-Filo) utilizes a viral vector strategy in which viruses – in this case adenovirus serotype 26 (Ad26) and Modified Vaccinia Virus Ankara (MVA) – are genetically modified so that they cannot replicate in human cells. In addition, these vectors are modified to safely carry the genetic code of an Ebola virus protein in order...
Source: Johnson and Johnson - Category: Pharmaceuticals Tags: Innovation Source Type: news
As nations around the world scramble to bring coronavirus outbreaks under control, Dr. Raj Panjabi is worried that the world’s poor populations will be excluded from accessing treatments and prevention measures, a scenario he calls “viral apartheid.” “I don’t use that term lightly,” said Panjabi, speaking with TIME Senior Writer Alice Park during a TIME 100 Talks discussion on May 28. “The idea that a group of people—whether it’s the vaccines, the test or treatments—will get access to those vital life-saving tools, and that those will likely be the rich nations an...
Source: TIME: Health - Category: Consumer Health News Authors: Tags: Uncategorized COVID-19 TIME100 Talks Source Type: news
As nations around the world scramble to bring coronavirus outbreaks under control, Dr. Raj Panjabi is worried that the world’s poor populations will be excluded from accessing treatments and prevention measures, a scenario he calls “viral apartheid.” “I don’t use that term lightly,” said Panjabi, speaking with TIME Senior Writer Alice Park during a TIME 100 Talks discussion on May 28. “The idea that a group of people—whether it’s the vaccines, the test or treatments—will get access to those vital life-saving tools, and that those will likely be the rich nations an...
Source: TIME: Health - Category: Consumer Health News Authors: Tags: Uncategorized COVID-19 TIME100 Talks Source Type: news
The global novel coronavirus pandemic afflicting everyone is showing mixed signs of activity. In some countries it appears to be easing, while in others it appears to be experiencing a resurgence. It’s not at all clear when the pandemic will end, but it’s unlikely to do so before 2021. What has become increasingly clear is that the toll of the pandemic will impact more than the people who come down with COVID-19. The mental health impact of living with a pandemic is being mostly ignored — for now. But as the deaths continue to rise, we need to pay close attention to the cost of the pandemic’s reperc...
Source: World of Psychology - Category: Psychiatry & Psychology Authors: Tags: General Grief and Loss Health-related Mental Health and Wellness Policy and Advocacy coronavirus COVID-19 Source Type: blogs
I live-tweeted a fascinating and perhaps rather depressing meeting with William Haseltine via a Reuters Newsmaker Broadcast. His talk was upbeat but the message does not offer a positive outlook unless we can collaborate internationally to identify, trace, and isolate and go back to early antivirals to treat people urgently. A vaccine will probably never be found, we must stay on top of this virus when we get communities under control. Moreover, we must recognise that another emergent pathogen could appear any time. These are essentially my notes from Haseltines’s talk. Might we ever achieve herd immunity? There is n...
Source: David Bradley Sciencebase - Songs, Snaps, Science - Category: Science Authors: Tags: Sciencebase Source Type: blogs
I live-tweeted a fascinating and perhaps rather depressing meeting with William Haseltine via a Reuters Newsmaker Broadcast. His talk was upbeat but the message does not offer a positive outlook unless we can collaborate internationally to identify, trace, and isolate and go back to early antivirals to treat people urgently. A vaccine will probably never be found, we must stay on top of this virus when we get communities under control. Moreover, we must recognise that another emergent pathogen could appear any time. These are essentially my notes from Haseltines’s talk. Might we ever achieve herd immunity? There is n...
Source: David Bradley Sciencebase - Songs, Snaps, Science - Category: Science Authors: Tags: Sciencebase Source Type: blogs
Conclusion In 1919 George A. Soper1 wrote that the deadly Spanish Flu pandemic that swept around the earth was without any precedents, and that there had been no such catastrophe ‘so sudden, so devastating and so universal’. He remarked that, “The most astonishing thing about the pandemic was the complete mystery which surrounded it. Nobody seemed to know what the disease was, where it came from or how to stop it. Anxious minds are inquiring today whether another wave of it will come again”. With close to 3 million positive cases and around 0.2 million deaths worldwide, the coronavirus has compelle...
Source: IPS Inter Press Service - Health - Category: International Medicine & Public Health Authors: Tags: Asia-Pacific Civil Society Development & Aid Featured Global Headlines Health TerraViva United Nations Source Type: news
Abstract The 2019 coronavirus pandemic (COVID-19) continues to expand worldwide. Although the number of cases and the death rate among children and adolescents are reported to be low compared to adults, limited data have been reported. We urgently need to find treatment and vaccine to stop the epidemic. Vaccine development is in progress, but any approved and effective vaccine for COVID-19 is at least 12 to 18 months. The World Health Organization (WHO), the Center for Disease Control and Prevention (CDC), and the Food and Agriculture Organization (FAO) have issued instructions and strategies for containing COVID-...
Source: Infectious Disorders Drug Targets - Category: Infectious Diseases Authors: Tags: Infect Disord Drug Targets Source Type: research
One person in Wuhan eats an uncooked bat, and your local Walmart runs out of toilet paper. This is such a surreal scenario, no wonder people are looking for alternative answers to how their normal lives got blown into pieces in the matter of weeks. And while conspiracy theories are usually a marginal phenomenon, in this age of misinformation, these theories seem to take over the place of truth and science. While the truth is usually complex and often hard to understand, these clean-cut conspiracy narratives are designed to prey on pre-established suspicions, so they can seem like viable alternatives. And unfortunately, ...
Source: The Medical Futurist - Category: Information Technology Authors: Tags: Conspiracy theories Future of Medicine fda drug research coronavirus covid covid19 pandemic plandemic Source Type: blogs
More News: Biotechnology | Clinical Trials | Coronavirus | COVID-19 | Epidemics | Epidemiology | Health | Pandemics | Vaccines